Lipocine Inc. (LPCN) Institutional Ownership

Ownership Summary

Lipocine Inc. (NASDAQ:LPCN) is held by 26 institutional investors per 13F filings through December 2025.

• Their combined ownership stood at 30.1% of outstanding shares in December 2025, up from 9.8% in September 2025.
• Their total shares held in LPCN increased 223.07% quarter over quarter, and separately, investors owning Lipocine increased 44.44% from a year ago.
• Activity in LPCN broke down as 14 buyers, 3 sellers, and 9 unchanged among 26 total holders.
• Altogether, these fund groups held 1.63Mn shares in LPCN by December 2025, up by 1.13Mn shares quarter on quarter, and up 1.14Mn shares year over year.
• Squadron Capital Management LLC is the top holder of Lipocine as of December 31, 2025, with 530.0K shares representing 9.79% of outstanding stock.
• The most significant purchases of LPCN for the quarter ending December 2025 came from Squadron Capital Management LLC (530.0K), DIADEMA PARTNERS LP (260.94K), Ikarian Capital, LLC (199.54K), Persistent Asset Partners Ltd (70.58K), BOOTHBAY FUND MANAGEMENT, LLC (54.89K).
• Leading sellers of Lipocine shares for the quarter ending December 2025 were SUSQUEHANNA INTERNATIONAL GROUP, LLP (21.85K), OSAIC HOLDINGS, INC. (2.15K), Bank Of America Corp /De/ (46).
• Lipocine's 10 largest shareholders as of December 2025 include Squadron Capital Management LLC (530.0K), DIADEMA PARTNERS LP (260.94K), VANGUARD GROUP INC (221.87K), Ikarian Capital, LLC (199.54K), BlackRock, Inc. (89.27K), Persistent Asset Partners Ltd (70.58K), GEODE CAPITAL MANAGEMENT, LLC (62.45K), BOOTHBAY FUND MANAGEMENT, LLC (54.89K), RENAISSANCE TECHNOLOGIES LLC (37.4K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (24.91K) per Business Quant data.